RecruitingPhase 3NCT07167550

The Study of Efficacy and Safety of Dimephosphon® in Acute Ischemic Stroke

Multicenter, Randomized, Double-blind, Placebo-controlled Comparative Study of the Efficacy and Safety of the Drug Dimephosphon®, Concentrate for Solution for Intravenous Administration, 1 g, in Acute Ischemic Stroke Patients

Sponsor

Tatchempharmpreparaty, JSC

Enrollment

184 participants

Start Date

Sep 6, 2025

Study Type

INTERVENTIONAL

Conditions

Stroke Cerebrovascular Disorders Acute Stroke Ischemic Stroke Physiological Effects of Drugs

Summary

A multicenter, randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of Dimephosphon® in acute ischemic stroke

Eligibility

Min Age: 35 YearsMax Age: 80 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a drug called Dimephosphon® and a drug called Placebo for people with acute stroke, cerebrovascular disorders, and other related conditions. The study is currently recruiting participants at 6 locations. People eligible for this study include aged 35 Years to 80 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DRUGDimephosphon®

1 g/ml, concentrate for solution for intravenous infusion

DRUGPlacebo

Placebo IV solution

Locations(6)

State Budgetary Healthcare Institution of the Leningrad Region "Vsevolozhsk Interdistrict Clinical Hospital

Vsevolozhsk, Leningradskaya Oblast', Russia

State Budgetary Healthcare Institution "Research Institute - Regional Clinical Hospital No. 1 named after Professor S.V. Ochapovsky" of the Ministry of Health of the Krasnodar region

Krasnodar, Russia

Federal State Autonomous Educational Institution of Higher Education "Peoples' Friendship University of Russia named after Patrice Lumumba"

Moscow, Russia

The FSBI "Federal Center of Brain Research and Neurotechnologies" of the Federal Medical and Biological Agency

Moscow, Russia

Saint Petersburg State Budgetary Healthcare Institution "City Hospital No. 40 of the Kurortny District"

Saint Petersburg, Russia

State Budgetary Healthcare Institution "City Hospital No. 4 of Sochi" of the Ministry of Healthcare of the Krasnodar Region

Sochi, Russia

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07167550

Related Trials

Screening for Social Determinants of Health (SDOH) and Cognitive Function in Individuals With History of Stroke

NCT066159731 location

Early Closure of Left Atrial Appendage for Patients With Atrial Fibrillation and Ischemic Stroke Despite Anticoagulation Therapy

NCT0597668530 locations

Rehabilitation With and Without Robot and Allied Digital Technologies in Stroke Patients

NCT0654782727 locations

The Beneficial Effects of Naps on Motor Learning

NCT043121261 location

Facilitating Neuroplastic Changes of Acute Stroke Survivors

NCT064042683 locations